Design of Epitope-Based Peptide Vaccine against Pseudomonas aeruginosa Fructose Bisphosphate Aldolase Protein Using Immunoinformatics

Table 5

The population coverage of the whole world for the most promising epitopes of MHC I, MHC II, and MHC I and II combined.

Country	MHC I	MHC II	MHC I,II (combined)
World	88.75%	61.1%	95.62%

In the population coverage analysis of MHC II; 8 alleles were not included in the calculation; therefore, the above () percentages are for epitope sets excluding these alleles: HLA-DQA105:01/DQB103:01, HLA-DQA101:02/DQB106:02, HLA-DQA103:01/DQB103:02, HLA-DRB401:01, HLA-DRB501:01, HLA-DQA105:01/DQB102:01, HLA-DPA103:01/DPB104:02, HLA-DQA104:01/DQB104:02.